Bold move for Martek
Global omega-3 DHA leader Martek Biosciences Corporation has moved into product manufacture with the £123 million (£141m) acquisition of Amerifit Brands, a company that specialises in women’s and digestive health products.
The all-cash deal means Martek is now the owner of brands such as the probiotic supplement Culturelle, AZO for urinary tract infections and Estroven for menopause problems.
“Amerifit’s first-class sales and marketing infrastructure and proven management team for selling branded consumer health and wellness products provide Martek with a platform for accelerating the commercialisation of our nutritional product pipeline, says Martek CEO Steve Dubin.“I am excited at the prospect of being able to develop consumer brands for some of the exciting new products in Martek’s pipeline. This new capability will enable Martek to move up the value chain by getting closer to the consumer and should result in increased revenue and gross profit opportunities.
